title: Using organotypic (raft) epithelial tissue cultures for the biosynthesis and isolation of infectious human papillomaviruses.
abstract: Papillomaviruses have a strict tropism for epithelial cells, and they are fully reliant on cellular differentiation for completion of their life cycles, resulting in the production of progeny virions. Thus, a permissive environment for full viral replication in vitro-wherein virion morphogenesis occurs under cooperative viral and cellular cues-requires the cultivation of epithelium. Presented in the first section of this unit is a protocol to grow differentiating epithelial tissues that mimic many important morphological and biochemical aspects of normal skin. The technique involves growing epidermal cells atop a dermal equivalent consisting of live fibroblasts and a collagen lattice. Epithelial stratification and differentiation ensues when the keratinocyte-dermal equivalent is placed at the air-liquid interface. The apparent floating nature of the cell-matrix in this method led to the nickname "raft" cultures. The general technique can be applied to normal low passage keratinocytes, to cells stably transfected with papillomavirus genes or genomes, or keratinocytes established from neoplastic lesions. However, infectious papillomavirus particles have only been isolated from organotypic epithelial cultures initiated with cells that maintain oncogenic human papillomavirus genomes in an extrachomosomal replicative form. The second section of this unit is dedicated to a virion isolation method that minimizes aerosol and skin exposure to these human carcinogens. Although the focus of the protocols is on the growth of tissues that yields infectious papillomavirus progeny, this culture system facilitates the investigation of these fastidious viruses during their complex replicative cycles, and raft tissues can be manipulated and harvested at any point during the process. Importantly, a single-step virus growth cycle is achieved in this process, as it is unlikely that progeny virions are released to initiate subsequent rounds of infection.
authors.affiliation: Department of Molecular Genetics and Microbiology, The University of New Mexico School of Medicine, The UNM Cancer Center, Albuquerque, New Mexico.
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Ozbun
authors.forename: Nicole A
authors.initials: NA
authors.lastname: Patterson
mesh_terms: D016475:3T3 Cells; D000818:Animals; D018929:Cell Culture Techniques; D002460:Cell Line; D003094:Collagen / Q000502:physiology*; D004848:Epithelium / Q000821:virology*; D005347:Fibroblasts / Q000502:physiology*; D006801:Humans; D015603:Keratinocytes; D051379:Mice; D027383:Papillomaviridae / Q000302:isolation & purification*; D051381:Rats; D014776:Virus Cultivation / Q000379:methods*; D014779:Virus Replication / Q000502:physiology
chemical_list: D003094:Collagen
keywords: air-liquid interface; keratinocyte; organotypic epithelial tissue culture; papillomavirus; virion isolation
references.citation: J Cell Biol. 1987 Jul;105(1):427-40
references.pmid: 2440897
references.citation: Virus Res. 2010 Jan;147(1):113-22
references.pmid: 19896513
references.citation: J Virol. 2008 Jun;82(11):5190-7
references.pmid: 18367526
references.citation: J Gen Virol. 2002 Nov;83(Pt 11):2753-2763
references.pmid: 12388811
references.citation: J Infect Dis. 1997 Oct;176(4):1076-9
references.pmid: 9333171
references.citation: J Virol. 1975 May;15(5):1239-47
references.pmid: 167184
references.citation: J Virol. 1997 Oct;71(10):7381-6
references.pmid: 9311816
references.citation: Methods Mol Biol. 2011;731:467-70
references.pmid: 21516429
references.citation: J Virol. 2013 Mar;87(5):2508-17
references.pmid: 23255786
references.citation: Virology. 1963 Oct;21:258-63
references.pmid: 14070177
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9311-6
references.pmid: 15958530
references.citation: Pharmaceutics. 2012 Jan 06;4(1):26-41
references.pmid: 24300178
references.citation: Br J Dermatol. 1984 Jul;111 Suppl 27:219-22
references.pmid: 6743553
references.citation: Vaccine. 2012 Nov 20;30 Suppl 5:F34-54
references.pmid: 23199965
references.citation: Proc Natl Acad Sci U S A. 1988 Oct;85(19):7169-73
references.pmid: 2459699
references.citation: J Virol. 2004 Jan;78(2):751-7
references.pmid: 14694107
references.citation: Science. 1992 Aug 14;257(5072):971-3
references.pmid: 1323879